TrialAdvances in therapy2024

Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension.

Ekkehard Grünig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.